Summary The time for blocking neuromuscular transmission by botulinum toxin is lengthened in phrenic nerve-diaphragm preparation of rats sacrificed at various times after subcutaneous injection of toosendanin (7 mg/kg). This effect of toosendanin manifests itself 15 min after injection and lasts for 3 days. During this period the frequency of miniature end-plate potentials is increased.
It is well known that botulinum toxin (BoTX) is a potent poison for vertebrates due to its presynaptic blocking action on the neuromuscular junction of skeletal muscles. For a long time investigators have searched for effective antidotes against BoTX but without much success. Both CHANG et al. (1973b , 1974 and STERN et al. (1975) found a moderate antagonism between BoTX and some other presynaptic blockers, i. e. 13-bungarotoxin (13-BuTX) and black widow spider venom (BWSV). Although the mechanism of this antagonism is still unknown, it is interesting to note that both ~3-BuTX (LEE and CHANG, 1966; CHANG et al., 1973a) and BWSV (LoNGENECKER et al., 1970; CLARK et al., 1972) increase the frequency of miniature end-plate potentials (MEPP) in the initial phase of their action, whereas BoTX decreases it immediately.
We found that toosendanin, a triterpenoid derivative (C30H33011) extracted from the bark of Melia toosendan which has been used as an ascaris vermifuge in traditional Chinese medicine, is a moderately potent presynaptic blocker with an initial facilitatory action on MEPP discharge (SHIN et a!., 1981a (SHIN et a!., , b,1982 . We also found that toosendanin lengthened the time for blocking neuromuscular transmission by BoTX in the isolated rat phrenic nerve-diaphragm preparation (SHIN and Hsu, 1983) . In this work we try to answer the question whether toosendanin has the anti-botulismic effect in situ, and if so, whether it is related to its facilitatory action on MEPP discharge.
Rats were divided into experimental and control groups. Toosendanin was dissolved in 60 % propane-l,2-diol.
It was injected subcutaneously (7 mg/kg) to rats in the experimental group. Some toxic symptoms such as motionlessness, refusing to take food and to drink, paresis of the hind legs developed gradually to their maximum at a time varying from 1 to 24 hr and then disappeared within 72 hr after injection. Rats in the control group were injected with the solvent alone. The animals were sacrificed at 15 min, 2, 6 hr, and 1, 2, 3, 4, 5, 7 days after injection. The left and the right phrenic nerve-diaphragm preparations were made from each animal and mounted separately in different chambers filled with the Krebs solution ventilated by 95% 02+5% CO2 at 37°C. One preparation was used for MEPP recording and the other for recording the muscle twitch to determine the paralysis time by BoTX, i. e. the time taken for the twitch to decrease to 20% of the original. A type of botulinum toxin (2>< 10~ mouse LD50/ml) was used.
As shown in Table 1 , the lengthening of the BoTX paralysis time and the increase in MEPP frequency started to occur as early as 15 min after toosendanin injection. These changes reached their maximum within several hours and stayed at a high level for as long as 3 days (Table 1) . During this period the distribution of MEPP frequency among different junctions became much dispersed (Fig. 1) , but the MEPP size remained unchanged or showed some tendency to decrease. These results indicate that the anti-botulismic effect of toosendanin is probably Fig, 1 . Frequency distribution of MEPP in the phrenic nerve-diaphragm preparations prepared from rats sacrificed at various times after subcutaneous injection of toosendanin (7 mg/kg). Vol. 33, No. 4, 1983 related to its facilitatory action on the frequency of MEPP discharge. In a previous work it was shown that the spontaneous transmitter release became more dependent on the extracellular Ca2+ concentration during the facilitatory phase of the toosendanin action (SHIN et a!., 1982) . It has been interpreted as due to an increase in Ca2+ conductance in the presynaptic membrane by toosendanin. We suggest that the antagonistic action of toosendanin against botulinum poisoning may be due to the same mechanism.
